Last update Jan. 2, 2022
Very Low Risk
In polymer of denatured gelatin derived polypeptides linked with urea bridges. It is a plasma substitute that is used as a plasma volume expander in the treatment of hypovolemic shock. Administration by intravenous infusion.
Since the last update we have not found any published data on its excretion in breast milk.
Its very high molecular weight make it highly unlikely that significant quantities will pass into breast milk.
Its null oral bioavailability makes it difficult for it to pass to the infant plasma from ingested breast milk, except in premature infants and in the immediate neonatal period in which there may be greater intestinal permeability.
List of WHO essential medicines: compatible with breastfeeding. (WHO / UNICEF 2002)
We do not have alternatives for Polygeline since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.